Literature DB >> 19933829

Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.

Bernt Christian Hellerud1, Audun Aase, Tove Karin Herstad, Lisbeth Meyer Naess, Lisa Høyem Kristiansen, Anne-Marie Siebke Trøseid, Morten Harboe, Knut Tore Lappegård, Petter Brandtzaeg, E Arne Høiby, Tom Eirik Mollnes.   

Abstract

Certain complement defects are associated with an increased propensity to contract Neisseria meningitidis infections. We performed detailed analyses of complement-mediated defense mechanisms against N. meningitidis 44/76 with whole blood and serum from two adult patients who were completely C2 or C5 deficient. The C5-deficient patient and the matched control were also deficient in mannose-binding lectin (MBL). The proliferation of meningococci incubated in freshly drawn whole blood was estimated by CFU and quantitative DNA real-time PCR. The serum bactericidal activity and opsonophagocytic activity by granulocytes were investigated, including heat-inactivated postvaccination sera, to examine the influence of antimeningococcal antibodies. The meningococci proliferated equally in C2- and C5-deficient blood, with a 2 log(10) increase of CFU and 4- to 5-log(10) increase in DNA copies. Proliferation was modestly decreased in reconstituted C2-deficient and control blood. After reconstitution of C5-deficient blood, all meningococci were killed, which is consistent with high antibody titers being present. The opsonophagocytic activity was strictly C2 dependent, appeared with normal serum, and increased with postvaccination serum. Serum bactericidal activity was strictly dependent on C2, C5, and high antibody titers. MBL did not influence any of the parameters observed. Complement-mediated defense against meningococci was thus dependent on the classical pathway. Some opsonophagocytic activity occurred despite low levels of antimeningococcal antibodies but was more efficient with immune sera. Serum bactericidal activity was dependent on C2, C5, and immune sera. MBL did not influence any of the parameters observed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933829      PMCID: PMC2812193          DOI: 10.1128/IAI.01044-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease.

Authors:  A Aase; L M Naess; R H Sandin; T K Herstad; F Oftung; J Holst; I L Haugen; E A Høiby; T E Michaelsen
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

2.  Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.

Authors:  Tom Sprong; Petter Brandtzaeg; Michael Fung; Anne M Pharo; E Arne Høiby; Terje E Michaelsen; Audun Aase; Jos W M van der Meer; Marcel van Deuren; Tom E Mollnes
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

3.  Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.

Authors:  G A Jarvis; N A Vedros
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

4.  Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease.

Authors:  J Holst; B Feiring; J E Fuglesang; E A Høiby; H Nøkleby; I S Aaberge; E Rosenqvist
Journal:  Vaccine       Date:  2003-01-30       Impact factor: 3.641

5.  Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease.

Authors:  Reidun Øvstebø; Petter Brandtzaeg; Berit Brusletto; Kari Bente Foss Haug; Knut Lande; Ernst Arne Høiby; Peter Kierulf
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

6.  Mannose-binding lectin binds to two major outer membrane proteins, opacity protein and porin, of Neisseria meningitidis.

Authors:  Michele M Estabrook; Dominic L Jack; Nigel J Klein; Gary A Jarvis
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

7.  Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine.

Authors:  Alexander E Platonov; Irina V Vershinina; Edward J Kuijper; Ray Borrow; Helena Käyhty
Journal:  Vaccine       Date:  2003-10-01       Impact factor: 3.641

Review 8.  Impact of mannose-binding lectin on susceptibility to infectious diseases.

Authors:  Damon P Eisen; Robyn M Minchinton
Journal:  Clin Infect Dis       Date:  2003-11-06       Impact factor: 9.079

Review 9.  Host genetic determinants of Neisseria meningitidis infections.

Authors:  M Emonts; J A Hazelzet; R de Groot; P W M Hermans
Journal:  Lancet Infect Dis       Date:  2003-09       Impact factor: 25.071

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  13 in total

1.  Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source.

Authors:  C J Gill; S Ram; J A Welsch; L Detora; A Anemona
Journal:  Vaccine       Date:  2011-11-07       Impact factor: 3.641

2.  Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.

Authors:  Davide Serruto; Rino Rappuoli; Maria Scarselli; Piet Gros; Jos A G van Strijp
Journal:  Nat Rev Microbiol       Date:  2010-06       Impact factor: 60.633

3.  Artificial surface-induced inflammation relies on complement factor 5: proof from a deficient person.

Authors:  Grethe Bergseth; John D Lambris; Tom Eirik Mollnes; Knut Tore Lappegård
Journal:  Ann Thorac Surg       Date:  2011-02       Impact factor: 4.330

Review 4.  The complement system and adverse pregnancy outcomes.

Authors:  Jean F Regal; Jeffrey S Gilbert; Richard M Burwick
Journal:  Mol Immunol       Date:  2015-03-21       Impact factor: 4.407

5.  Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage.

Authors:  Constance M John; Nancy J Phillips; Richard Din; Mingfeng Liu; Einar Rosenqvist; E Arne Høiby; Daniel C Stein; Gary A Jarvis
Journal:  J Biol Chem       Date:  2015-12-11       Impact factor: 5.157

6.  Novel Mutations Causing C5 Deficiency in Three North-African Families.

Authors:  Roger Colobran; Clara Franco-Jarava; Andrea Martín-Nalda; Neus Baena; Elisabeth Gabau; Natàlia Padilla; Xavier de la Cruz; Ricardo Pujol-Borrell; David Comas; Pere Soler-Palacín; Manuel Hernández-González
Journal:  J Clin Immunol       Date:  2016-03-30       Impact factor: 8.317

7.  Human Endothelial Cell Activation by Escherichia coli and Staphylococcus aureus Is Mediated by TNF and IL-1β Secondarily to Activation of C5 and CD14 in Whole Blood.

Authors:  Stig Nymo; Alice Gustavsen; Per H Nilsson; Corinna Lau; Terje Espevik; Tom Eirik Mollnes
Journal:  J Immunol       Date:  2016-01-22       Impact factor: 5.422

Review 8.  Antibody-mediated complement activation in pathology and protection.

Authors:  Benjamin S Goldberg; Margaret E Ackerman
Journal:  Immunol Cell Biol       Date:  2020-04-06       Impact factor: 5.126

Review 9.  Meningococcal disease and the complement system.

Authors:  Lisa A Lewis; Sanjay Ram
Journal:  Virulence       Date:  2013-10-08       Impact factor: 5.882

10.  Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method.

Authors:  Mi Seon Jang; Sushant Sahastrabuddhe; Cheol-Heui Yun; Seung Hyun Han; Jae Seung Yang
Journal:  Microb Pathog       Date:  2016-05-20       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.